A randomized, double-blind study to evaluate the safety and tolerability of KB174, a novel synthetic glycan, in patients with well-compensated cirrhosis

Autor:	Bal Raj Bhandari, Jeffrey Cehelsky, Yan Zheng, Mark Wingertzahn, Norma Palma, Robert S Mittleman
Rok vydání:	2020
Předmět:	Hepatology
Zdroj:	Journal of Hepatology. 73:S699
ISSN:	0168-8278
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::69187c3042152b1b526e9f5c9fc3834e https://doi.org/10.1016/s0168-8278(20)31858-4 Zobrazit plný text záznamu Full Text from ScienceDirect